News

The Dermatology Innovation Forum has announced its cancellation amid global spread of the coronavirus.

The American Academy of Dermatology Board of Directors has decided to cancel the 2020 Annual Meeting in Denver due to coronavirus concerns.

A dermatologist performed a large excision on a patient without taking a medication history, and the patient experienced progressive post-operative bleeding. Was he negligent? Dr. Goldberg discusses this hypothetical case and the nuances of physician negligence in this Legal Eagle article.

It’s known that combination therapies can be used to create ideal treatment outcomes, but according to Dr. Suneel Chilukuri, results may also last longer than originally thought.

Millennials think of aesthetic treatments no differently than other beauty appointments, according to Dr. Ava Shamban. These are their top facial concerns. 

The FDA announced it has accepted a priority review of dupilumab for the treatment of moderate-to-severe AD in pediatric patients 6 to 11 years of age. The drug is already approved for treatment of AD in adolescents and adults.

In a skit depicting Carnac the Magnificent, Drs. Rosen and Bhatia presented on 2020's new drugs and technologies at the current Maui Derm for Dermatologists, all with a magical twist.

Investigative cryolipolysis technique holds promise as a new strategy for selective, nonsurgical fat reduction.

Medical device company Soliton presents results from their 12-week study looking at the treatment of fibrotic scars via their RAP device at Maui Derm.

In his presentation at the current Maui Derm 2020, Dr. Curtis Cole tackled the controversy of how SPF labeling can differ significantly from the actual protection.

An analysis by Vanguard Communications suggests more weight is attached to physician patient reviews compared to those of hotels and restaurants.

South Florida practitioner Dr. Susan Weinkle received the JDD Outstanding Educator & Mentor in Dermatology at the ODAC held Jan.17-20 in Orlando, Fla. The award recognizes continuing contributions to the dermatology industry through education.

Verrica released positive data from its post-hoc pooled analysis of pivotal phase 3 trials investigating the safety and efficacy of VP-102 for the treatment of molluscum contagiosum.

Medical device company, Soliton will present results from their 12-week study looking at the treatment of fibrotic scars using their RAP device at Maui Derm Jan. 25-29.

Hans Hofland, Ph.D, and Dr. Steve Xu shine a spotlight on Dermira and its novel topical medicine indicated for primary axillary hyperhidrosis in patients 9 years of age and older.

The distribution agreement between Revance and Swiss HA-based dermal filler and cosmeceutical manufacturing company, TEOXANE SA, may position Revance as a leader in the U.S. facial injectable market.

A variety of topical CBD products are becoming increasingly available to patients, but do they actually work? These experts believe more research is needed to create CBD-containing dermatology products that can effectively treat skin disorders.

Prebiotics, probiotics, postbiotics and peptides - according to Dr. Manjula Jegasothy, all eyes should be on these.

Results from an EU phase 3 clinical trial of a combination of betamethasone dipropionate and calcipotriene cream showed improved patient convenience, quality of life and efficacy compared to a betamethasone dipropionate and calcipotriene gel for patients with plaque psoriasis.

From plasma energy to CBD in skincare, these are a few of the hot topics the Dermatology Times team covered in 2019 that are worthy of keeping an eye on in 2020.

Dr. Joel Schlessinger prides himself on creating an interactive and open discussion opportunity at Cosmetic Surgery Forum, and he says his reasoning is simple: Why speculate when the experts are in the room?

Medical aesthetic company Cynosure announces TempSure Firm, a new RF treatment for stubborn cellulite.

Performing fungal diagnostic preparations to confirm a suspected fungal infection should be a central tenant in dermatology, says this expert. But more than one-fifth of dermatologists surveyed said they never or rarely do fungal preparations in practice.

A recent study examines the safety and efficacy of picosecond laser as a melasma treatment during a time when lasers are increasingly being used to treat the condition.

The United States Food and Drug Administration has granted Galderma’s nemolizumab a Breakthrough Therapy Designation following phase 2 results which suggests the drug is a considerable alleviant for pruritus associated with prurigo nodularis.

Leo Pharma A/S and Portal Instruments are now collaborating on a new needle-free handheld jet injector for patients that self-administer medicines for cutaneous diseases and ailments. 

In the decades that Dermatology Times reporters have covered the specialty, we’ve had the pleasure of profiling the specialty’s champions. Some shared their professional accomplishments, while others revealed unknown aspects of their personal lives. Here just some of the interesting tidbits from years’ past.

Study shows clinical benefit of PRP in a stabilized vehicle for SoME Skincare product.

Allan C. Halpern, M.D., discusses what dermatologists need to understand about AI and how it might interact with or disrupt the specialty.